Giuseppe Del Giudice spends much of his time researching Microbiology, Immunology, Antibody, Immunogenicity and Immune system. His Microbiology research incorporates themes from Helicobacter pylori, Spirillaceae, Bacterial vaccine and Pathogenicity island. As part of his studies on Immunology, Giuseppe Del Giudice often connects relevant subjects like Virology.
His Antibody research focuses on Priming and how it connects with Humoral immunity and Heat shock protein. His Immunogenicity research is multidisciplinary, incorporating elements of Molecular biology, In vitro, Immunogen and Mutant. His Vaccination course of study focuses on T cell and Secretion.
Giuseppe Del Giudice mainly focuses on Immunology, Vaccination, Microbiology, Virology and Immune system. His work in Vaccination addresses subjects such as Gerontology, which are connected to disciplines such as Population ageing. His Microbiology research includes themes of Humoral immunity, Helicobacter pylori, In vivo and Toxoid.
His Virology study combines topics in areas such as Epitope, Circumsporozoite protein, Antigen and Immunogenicity. His study explores the link between Immune system and topics such as Bone marrow that cross with problems in Spleen. The study incorporates disciplines such as Priming and Ratón in addition to Antibody.
Vaccination, Immunology, Immune system, Gerontology and Public health are his primary areas of study. His research in Vaccination intersects with topics in Immunization and Intensive care medicine. He integrates Immunology with Identification in his research.
When carried out as part of a general Immune system research project, his work on Adjuvanticity is frequently linked to work in Herpes Zoster Vaccine, therefore connecting diverse disciplines of study. His Antigen study incorporates themes from Molecular biology and T cell. His study in Adjuvant is interdisciplinary in nature, drawing from both Plasma cell and Antibody.
His scientific interests lie mostly in Vaccination, Psychological intervention, Immune system, Gerontology and Public health. Giuseppe Del Giudice interconnects Innate immune system, Adjuvanticity, myalgia and Health professionals in the investigation of issues within Vaccination. His Immune system research is under the purview of Immunology.
His work on Whooping cough, Inflammation and Measles as part of general Immunology study is frequently connected to Transcriptome, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. Giuseppe Del Giudice combines subjects such as Developed country, Vaccine-preventable diseases, Immunization and Immunosenescence with his study of Gerontology. In general Public health, his work in Biostatistics is often linked to Diversity linking many areas of study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Helicobacter pylori virulence and genetic geography.
Antonello Covacci;John L. Telford;Giuseppe Del Giudice;Julie Parsonnet.
The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor.
Barbara Satin;Giuseppe Del Giudice;Vittorina Della Bianca;Stefano Dusi.
Journal of Experimental Medicine (2000)
Correlates of adjuvanticity: A review on adjuvants in licensed vaccines.
Giuseppe Del Giudice;Rino Rappuoli;Arnaud M. Didierlaurent.
Seminars in Immunology (2018)
MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines
Surender Khurana;Nitin Verma;Jonathan W. Yewdell;Anne Katrin Hilbert.
Science Translational Medicine (2011)
Mucosal Adjuvanticity and Immunogenicity of LTR72, a Novel Mutant of Escherichia coli Heat-labile Enterotoxin with Partial Knockout of ADP-ribosyltransferase Activity
Marzia Monica Giuliani;Giuseppe Del Giudice;Valentina Giannelli;Gordon Dougan.
Journal of Experimental Medicine (1998)
Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children
Steven Black;Uwe Nicolay;Timo Vesikari;Markus Knuf.
Pediatric Infectious Disease Journal (2011)
Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus
Surender Khurana;Wanida Chearwae;Flora Castellino;Jody Manischewitz.
Science Translational Medicine (2010)
MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile.
Audino Podda;Giuseppe Del Giudice.
Expert Review of Vaccines (2003)
Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels
Grazia Galli;Duccio Medini;Erica Borgogni;Luisanna Zedda.
Proceedings of the National Academy of Sciences of the United States of America (2009)
Mycobacterial heat-shock proteins as carrier molecules. II: The use of the 70-kDa mycobacterial heat-shock protein as carrier for conjugated vaccines can circumvent the need for adjuvants and Bacillus Calmette Guérin priming.
Christy Barrios;Alexander R. Lussow;Jan Van Embden;Ruurd Van Der Zee.
European Journal of Immunology (1992)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: